• Users Online: 98
  • Print this page
  • Email this page
Year : 2021  |  Volume : 11  |  Issue : 4  |  Page : 348-351

Gene therapy for retinitis pigmentosa

Department of Ophthalmology, School of Medicine, Saint Louis University, St. Louis, MO, USA

Correspondence Address:
Dr. Niloofar Piri
1225 S Grand Blvd, Saint Louis, MO, 63104
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjo.tjo_47_21

Rights and Permissions

Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RP) is the most common cause of RP in North America. There is no proven cure for the disease, and multiple approaches are being studied. Gene therapy is an evolving field in medicine and ophthalmology. In this review, we will go over the basic concept of gene therapy and the different types of gene therapy that are currently being studied to treat this disease.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded547    
    Comments [Add]    

Recommend this journal